Trial Profile
A Phase l/ll trial of Trabedersen for malignant melanoma.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Sep 2016
Price :
$35
*
At a glance
- Drugs Trabedersen (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 27 Sep 2016 New trial record